Pharmacological intervention in the initial prodromal phase of psychosis

European Psychiatry

Volumn 20, Issue 1, 2005, Pages 1-6

  Ruhrmann, Stephan ^a   Schultze Lutter, Frauke ^a   Maier, Wolfgang ^b   Klosterkötter, Joachim ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Early intervention; German Research Network on Schizophrenia; Prodromal phase; Psychosis; Schizophrenia

Indexed keywords

AMISULPRIDE; FISH OIL; GLYCINE; ICOSAPENTAENOIC ACID; LITHIUM; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EARLY DIAGNOSIS; GENETIC ANALYSIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MENTAL PATIENT; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; PSYCHOTHERAPY; RELAPSE; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; TREATMENT OUTCOME;

EID: 11844279765     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.11.001     Document Type: Article

References (58)

1. D. Addington, J. Addington, and S. Patten Depression in people with first-episode schizophrenia Br. J. Psychiatry 172 1998 S90 S92
2. S. Andreasson, P. Allebeck, A. Engstrom, and U. Rydberg Cannabis and schizophrenia. A longitudinal study of Swedish conscripts Lancet 2 1987 1483 1486
3. P. Bebbington, S. Wilkins, P. Jones, A. Foerster, R. Murray, and B. Toone Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study Br. J. Psychiatry 162 1993 72 79
4. G.E. Berger, S. Wood, and P.D. McGorry Incipient neurovulnerability and neuroprotection in early psychosis Psychopharmacol Bull 37 2003 79 101
5. M. Birchwood, and J.F. McMillan Early intervention in schizophrenia Aust. N. Z. J. Psychiatry 27 1993 374 378
6. J. Boydell, J. Van Os, K. McKenzie, J. Allardyce, R. Goel, and R.G. McCreadie Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment Br Med J 323 2001 1336 1338
7. S. Brown, and J. Birtwistle People with schizophrenia and their families. Fifteen-year outcome Br. J. Psychiatry 173 1998 139 144
8. M.L. Bruce, D.T. Takeuchi, and P.J. Leaf Poverty and psychiatric status. Longitudinal evidence from the New Haven Epidemiologic Catchment Area study Arch. Gen. Psychiatry 48 1991 470 474
9. B.A. Cornblatt The New York high risk project to the Hillside recognition and prevention (RAP) program Am J Med Genet 114 2002 956 956
10. B.A. Cornblatt, T. Lencz, C.W. Smith, C.U. Correll, A.M. Auther, and E. Nakayama The schizophrenia prodrome revisited: a neurodevelopmental perspective Schizophr Bull 29 2003 633 651
11. D. DeGrazia Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia Schizophr Res 51 2001 77 86
12. I.I. Gottesman Schizophrenia epigenesis: past, present, and future Acta Psychiatr. Scand. 384 1994 S26 S33
13. G.L. Haas, L.S. Garratt, and J.A. Sweeney Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness J. Psychiatr. Res. 32 1998 151 159
14. M. Hambrecht, and H. Häfner Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective Aust New Zealand J Psychiatry 34 2000 468 475
15. M. Hambrecht, M. Lammertink, J. Klosterkötter, E. Matuschek, and R. Pukrop Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic Br J Psychiatry Suppl 43 2002 S30 S37
16. R.K. Heinssen, D.O. Perkins, P.S. Appelbaum, and W.S. Fenton Informed consent in early psychosis research: National Institute of Mental Health Workshop, November 15, 2000 Schizophr Bull 27 2001 563 570
17. L. Helgason Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr. Scand. 81 1990 231 235
18. G. Huber Reine Defektsyndrome und Basisstadien endogener Psychosen Fortschr. Neurol. Psychiatr. 34 1966 409 426
19. M.S. Humphreys, E.C. Johnstone, J.F. MacMillan, and P.J. Taylor Dangerous behaviour preceding first admissions for schizophrenia Br. J. Psychiatry 161 1992 501 505
20. H. Häfner, and B. Nowotny Epidemiology of early-onset schizophrenia Eur. Arch. Psychiatry Clin. Neurosci. 245 1995 80 92
21. H. Häfner, W. Löffler, K. Maurer, M. Hambrecht, and W. Der Heiden Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia Acta Psychiatr. Scand. 100 1999 105 108
22. H. Häfner, K. Maurer, S. Ruhrmann, A. Bechdolf, J. Klosterkötter, and M. Wagner Early detection and secondary prevention of psychosis: facts and visions Eur Arch Psychiatry Clin Neurosci 254 2004 117 128
23. A. Jablensky The 100-year epidemiology of schizophrenia Schizophr. Res. 28 1997 111 125
24. J.O. Johannessen, T.H. McGlashan, T.K. Larsen, M. Horneland, I. Joa, and S. Mardal Early detection strategies for untreated first-episode psychosis Schizophr Res 51 2001 39 46
25. E.C. Johnstone, T.J. Crow, A.L. Johnson, and J.F. McMillan The Northwick Park study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission Br. J. Psychiatry 148 1986 115 120
26. J.M. Kane, J. Krystal, and C.U. Corell Treatment models and designs for intervention research during the psychotic prodrome Schizophr Bull 29 2003 747 756
27. J. Klosterkötter, and F. Schultze-Lutter Is there a primary prevention of schizophrenic psychiosis? Fortschr Neurol Psychiatr 69 2001 S104 S112 [Article in German]
28. T. Kolakowska, A.O. Williams, M. Ardern, M.A. Reveley, K. Jambor, and M.G. Gelder Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction Br. J. Psychiatry 146 1985 229 239
29. A.R. Koreen, S.G. Siris, M. Chakos, J. Alvir, D. Mayerhoff, and J. Lieberman Depression in first-episode schizophrenia Am. J. Psychiatry 150 1993 1643 1648
30. T.K. Larsen, J.O. Johannessen, and S. Opjordsmoen First-episode schizophrenia with long duration of untreated psychosis. Pathways to care Br. J. Psychiatry 172 1998 S45 S52
31. J.A. Lieberman, B.B. Sheitman, and B.J. Kinon Endogenous neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neural regulation and plasticity Neuropsychopharmacology 17 1997 205 209
32. J.A. Lieberman, D. Perkins, A. Belger, M. Chakos, F. Jarskog, and K. Boteva The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches Biol Psychiatry 50 2001 884 897
33. A.D. Loebel, J.A. Lieberman, J.M. Alvir, D.I. Mayerhoff, S.H. Geisler, and S.R. Szymanski Duration of psychosis and outcome in first-episode schizophrenia Am. J. Psychiatry 149 1992 1183 1188
34. T.H. McGlashan Psychosis treatment prior to psychosis onset: ethical issues Schizophr Res 51 2001 47 54
35. McGlashan TH. Abstract presented at the Twelfth Biennial Winter Workshop on Schizophrenia. Davos, Switzerland, 7-13 February 2004.
36. P.D. McGorry, J. Edwards, C. Mihalopoulos, S.M. Harrigan, and H.J. Jackson EPPIC: an evolving system of early detection and optimal management Schizophr. Bull. 22 1996 305 326
37. P.D. McGorry, A.R. Yung, L.J. Phillips, H.P. Yuen, S. Francey, and E.M. Cosgrave Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms Arch Gen Psychiatry 59 2002 921 928
38. P.D. McGorry, A.R. Yung, and L.J. Phillips The "close-in" or ultra high-risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder Schizophr Bull 29 2003 771 790
39. J. McGrath, S. Saha, J. Welham, O. El Saadi, C. MacCauley, and D. Chant A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology BMC Med 2 2004 13
40. M. McGue, and I.I. Gottesman The genetic epidemiology of schizophrenia and the design of linkage studies Eur. Arch. Psychiatry Clin. Neurosci. 240 1991 174 181
41. P. Miller, S.M. Lawrie, A. Hodges, R. Clafferty, R. Cosway, and E.C. Johnstone Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia Soc Psychiatry Psychiatr Epidemiol 36 2001 338 342
42. T.J. Miller, R.B. Zipursky, D. Perkins, J. Addington, S.W. Woods, and K.A. Hawkins The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample Schizophr Res 61 2003 19 30
43. E. O'Callaghan, T. Gibson, H.A. Colohan, P. Buckley, D.G. Walshe, and C. Larkin Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study BMJ 305 1992 1256 1259
44. L.J. Phillips, A.R. Yung, and P.D. McGorry Identification of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria Aust New Zealand J Psychiatry 34 2000 S164 S169
45. M. Pollack, M.G. Woerner, W. Goodman, and I.M. Greenberg Childhood development patterns of hospitalized adult schizophrenic and non-schizophrenic patients and their siblings Am. J. Orthopsychiatry 36 1966 510 517
46. S. Ruhrmann, F. Schultze-Lutter, and J. Klosterkötter Early detection and intervention in the initial prodromal phase of schizophrenia Pharmacopsychiatry 36 2003 S162 S167
47. S. Ruhrmann, F. Schultze-Lutter, H. Von Reventlow, H. Picker, S. Tschinkel, and B. Bühler Functional disability in the prodromal phase of psychosis Eur Psychiatry 19 2004 S11
48. F. Schultze-Lutter Prediction of psychosis is necessary and possible C. McDonald K. Schulze R. Murray P. Wright Schizophrenia: challenging the orthodox 2004 Taylor & Francis London, New York 81 90
49. J.P. Selten, J.P. Slaets, and R.S. Kahn Schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence Psychol. Med. 27 1997 807 811
50. P.C. Sham, E. O'Callaghan, N. Takei, G.K. Murray, E.H. Hare, and R.M. Murray Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960 Br. J. Psychiatry 160 1992 461 466
51. J. Stirling, D. Tantam, P. Thomas, D. Newby, L. Montague, and N. Ring Expressed emotion and early onset schizophrenia: a 1:year follow-up Psychol. Med. 21 1991 675 685
52. S.M. Strakowski, P.E. Keck Jr., S.L. McElroy, H.S. Lonczak, and S.A. West Chronology of comorbid and principal syndromes in first-episode psychosis Compr. Psychiatry 36 1995 106 112
53. R.D. Strous, J.M. Alvir, D. Robinson, G. Gal, B. Sheitman, and M. Chakos Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects Schizophr Bull 30 2004 265 278
54. E. Susser, R. Neugebauer, H.W. Hoek, A.S. Brown, S. Lin, and D. Labovitz Schizophrenia after prenatal famine. Further evidence Arch. Gen. Psychiatry 53 1996 25 31
55. S.W. Woods, T.J. Miller, and T.H. McGlashan The 'prodromal' patient: Both, symptomatic and at risk CNS Spectr 6 2001 223 232
56. S.W. Woods, A. Breier, R.B. Zipursky, D.O. Perkins, J. Addington, and T.J. Miller Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome Biol Psychiatry 54 2003 453 464
57. W. Wölwer, G. Buchkremer, H. Häfner, J. Klosterkotter, W. Maier, and H.J. Moller German research network on schizophrenia-bridging the gap between research and care Eur Arch Psychiatry Clin Neurosci 253 2003 321 329
58. A.R. Yung, L.J. Phillips, P.D. McGorry, C.A. McFarlane, S. Francey, and S. Harrigan Prediction of psychosis. A step towards indicated prevention of schizophrenia Br. J. Psychiatry Suppl. 172 1998 S14 S20